Nifty
Sensex
:
:
13109.05
44655.44
140.10 (1.08%)
505.72 (1.15%)

Pharmaceuticals & Drugs

Rating :
63/99

BSE: 524654 | NSE: Not Listed

85.50
01-Dec-2020
  • Open
  • High
  • Low
  • Previous Close
  •  82.20
  •  86.10
  •  82.20
  •  82.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  24
  •  1.26
  •  99.90
  •  32.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 51.26
  • 12.78
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 56.60
  • 0.73%
  • 0.87

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 52.17%
  • 0.00%
  • 30.80%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 17.03%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.07
  • -0.16
  • 3.97

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.82
  • -10.94
  • -0.36

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -15.20
  • -27.66
  • -8.15

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 15.12
  • 17.08

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.15
  • 0.36
  • 0.62

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.55
  • 3.71
  • 6.42

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
18.65
15.52
20.17%
16.00
14.02
14.12%
15.65
15.84
-1.20%
16.37
15.33
6.78%
Expenses
16.21
14.60
11.03%
14.40
12.79
12.59%
14.14
14.81
-4.52%
14.74
14.06
4.84%
EBITDA
2.44
0.92
165.22%
1.60
1.23
30.08%
1.51
1.03
46.60%
1.63
1.27
28.35%
EBIDTM
13.14%
5.93%
10.00%
8.77%
14.01%
6.50%
9.96%
8.28%
Other Income
0.17
0.26
-34.62%
0.34
0.27
25.93%
0.21
0.09
133.33%
0.22
0.32
-31.25%
Interest
0.04
0.16
-75.00%
0.15
0.15
0.00%
0.19
0.14
35.71%
0.27
0.13
107.69%
Depreciation
1.05
0.75
40.00%
1.03
0.90
14.44%
1.32
0.34
288.24%
1.15
0.67
71.64%
PBT
1.53
0.27
466.67%
2.94
0.45
553.33%
0.21
0.64
-67.19%
0.43
0.40
7.50%
Tax
0.35
0.12
191.67%
0.46
0.10
360.00%
0.10
-0.27
-
0.19
0.08
137.50%
PAT
1.18
0.15
686.67%
2.48
0.35
608.57%
0.11
0.91
-87.91%
0.24
0.32
-25.00%
PATM
6.33%
0.97%
15.50%
2.50%
7.11%
5.74%
1.47%
2.09%
EPS
1.90
0.24
691.67%
4.00
0.56
614.29%
0.18
1.47
-87.76%
0.39
0.52
-25.00%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Mar 18
Net Sales
66.67
61.55
59.78
54.76
Net Sales Growth
9.82%
2.96%
9.17%
 
Cost Of Goods Sold
4,668.58
28.03
26.49
23.81
Gross Profit
-4,601.91
33.52
33.29
30.95
GP Margin
-6,902.52%
54.46%
55.69%
56.52%
Total Expenditure
59.49
56.11
54.73
49.22
Power & Fuel Cost
-
8.16
8.89
6.79
% Of Sales
-
13.26%
14.87%
12.40%
Employee Cost
-
5.91
5.57
5.23
% Of Sales
-
9.60%
9.32%
9.55%
Manufacturing Exp.
-
5.56
5.92
4.80
% Of Sales
-
9.03%
9.90%
8.77%
General & Admin Exp.
-
3.51
3.63
3.07
% Of Sales
-
5.70%
6.07%
5.61%
Selling & Distn. Exp.
-
4.46
3.92
5.20
% Of Sales
-
7.25%
6.56%
9.50%
Miscellaneous Exp.
-
0.49
0.30
0.32
% Of Sales
-
0.80%
0.50%
0.58%
EBITDA
7.18
5.44
5.05
5.54
EBITDA Margin
10.77%
8.84%
8.45%
10.12%
Other Income
0.94
0.95
1.14
0.81
Interest
0.65
0.91
0.53
0.33
Depreciation
4.55
4.12
3.20
4.33
PBT
5.11
1.37
2.46
1.68
Tax
1.10
0.51
0.15
0.57
Tax Rate
21.53%
37.23%
7.25%
33.93%
PAT
4.01
0.86
1.92
1.11
PAT before Minority Interest
4.01
0.86
1.92
1.11
Minority Interest
0.00
0.00
0.00
0.00
PAT Margin
6.01%
1.40%
3.21%
2.03%
PAT Growth
131.79%
-55.21%
72.97%
 
EPS
6.47
1.39
3.10
1.79

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Shareholder's Funds
55.62
55.49
54.32
Share Capital
6.23
6.23
6.23
Total Reserves
49.39
49.26
48.09
Non-Current Liabilities
1.08
1.23
1.88
Secured Loans
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
Long Term Provisions
0.14
0.15
0.15
Current Liabilities
17.99
16.42
14.86
Trade Payables
6.96
8.25
12.05
Other Current Liabilities
4.65
2.63
1.84
Short Term Borrowings
6.26
5.41
0.00
Short Term Provisions
0.11
0.13
0.96
Total Liabilities
74.69
73.14
71.06
Net Block
23.81
24.37
21.88
Gross Block
69.64
66.07
61.49
Accumulated Depreciation
45.83
41.71
39.61
Non Current Assets
36.98
34.79
29.42
Capital Work in Progress
2.11
2.45
1.03
Non Current Investment
5.57
5.07
5.07
Long Term Loans & Adv.
4.69
2.09
0.48
Other Non Current Assets
0.79
0.81
0.96
Current Assets
37.71
38.36
41.64
Current Investments
0.00
0.00
0.00
Inventories
5.28
4.32
7.70
Sundry Debtors
30.36
32.20
31.26
Cash & Bank
0.93
0.50
0.91
Other Current Assets
1.14
0.07
0.22
Short Term Loans & Adv.
1.04
1.27
1.54
Net Current Assets
19.72
21.94
26.78
Total Assets
74.69
73.15
71.06

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Cash From Operating Activity
7.20
2.10
5.35
PBT
1.37
2.07
1.68
Adjustment
4.85
3.89
4.58
Changes in Working Capital
1.64
-3.07
-0.92
Cash after chg. in Working capital
7.86
2.89
5.35
Interest Paid
0.00
0.00
0.00
Tax Paid
-0.66
-0.79
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-5.74
-7.06
-0.93
Net Fixed Assets
-3.23
-6.00
Net Investments
-0.50
-0.01
Others
-2.01
-1.05
Cash from Financing Activity
-1.19
4.28
-3.93
Net Cash Inflow / Outflow
0.27
-0.68
0.49
Opening Cash & Equivalents
0.06
0.74
0.25
Closing Cash & Equivalent
0.33
0.06
0.74

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Book Value (Rs.)
89.24
89.04
87.16
ROA
1.16%
2.66%
1.56%
ROE
1.54%
3.50%
2.05%
ROCE
3.71%
4.51%
3.71%
Fixed Asset Turnover
0.91
0.94
0.89
Receivable days
185.47
193.73
208.38
Inventory Days
28.45
36.68
51.33
Payable days
48.48
69.74
83.44
Cash Conversion Cycle
165.44
160.67
176.26
Total Debt/Equity
0.11
0.10
0.00
Interest Cover
2.51
4.90
6.03

News Update:


  • Natural Capsules incorporates WOS company
    26th Aug 2020, 09:52 AM

    The company has incorporated a WOS company namely ‘Natural Biogenex’ on August 23, 2020

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.